Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis
Author:
Savage Thomas M.,
Fortson Katherine T.,
de los Santos-Alexis Kenia,
Oliveras-Alsina Angelica,
Rouanne Mathieu,
Rae Sarah S.,
Gamarra Jennifer R.,
Shayya Hani,
Kornberg Adam,
Cavero Renzo,
Li Fangda,
Han Arnold,
Haeusler Rebecca A.,
Adam Julien,
Schwabe Robert F.,
Arpaia NicholasORCID
Reference84 articles.
1. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention;Younossi;Nat. Rev. Gastroenterol. Hepatol.,2018
2. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016
3. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up;Ekstedt;Hepatology,2015
4. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease;Angulo;Gastroenterology,2015
5. Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease;Sanyal;N. Engl. J. Med.,2021
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献